# 2025-01-15 NHLBI BioData Catalyst Ecosystem Release Notes

### **Introduction**

The 2025-01-15 release marks the 20th release for the NHLBI BioData Catalyst® (BDC) ecosystem. This release includes several new features (e.g., storage cost savings and PFB handoff of cohort data) along with documentation and tutorials (e.g., video guides to BDC Data Studio environments) to help new users get started on the system. This release also includes enhanced support for working with cohort data. Please find more detail on the new features and user support materials in the sections below.

The 2025-01-15 data releases include the addition of studies on pulmonary fibrosis, COPD, asthma, and congenital heart defects, along with new imaging from atherosclerosis and echocardiogram studies. Updates also include research on cardiovascular health, genetic epidemiology, COVID-19, blood pressure, veteran health, and lifestyle interventions. Please refer to the Data Releases section below for more information as well as the[ Data page](https://biodatacatalyst.nhlbi.nih.gov/resources/data) on the BDC website.

### **Significant new features**

**Save on storage costs in Terra with bucket lifecycle rules:** This feature on *BDC Powered by Terra (BDC-Terra)* gives users better controls to delete unnecessary workspace bucket files and manage cloud storage costs. [Learn more about bucket lifecycle rules here.](https://support.terra.bio/hc/en-us/articles/31182203937179-Save-storage-costs-with-bucket-lifecycle-rules-Released-12-6-24)

**PFB Handoff of Cohort Data from PIC-SURE to Terra:** After exploring data and adding filters to build a cohort of interest in *BDC Powered by PIC-SURE (BDC-PIC-SURE)*, investigators can now seamlessly move the participant-level data to *BDC-Terra* for analysis. This feature allows investigators to bring the data into a new or previously existing *BDC-Terra* workspace using the Portable Format for Bioinformatics, or PFB, format. This format includes two tables: the participant-level data and the associated data dictionary. [Learn more about handing off participant data from *BDC-PIC-SURE* to *BDC-Terra* here](https://pic-sure.gitbook.io/nhlbi-biodata-catalyst-powered-by-pic-sure/explore/features-of-explore/pfb-handoff-to-biodata-catalyst-powered-by-terra) and at [*BDC-Terra Support*](https://support.terra.bio/hc/en-us/articles/31787224295579-How-to-create-and-export-a-PIC-SURE-cohort).

**Links to Original Files from Selected Cohort Data:** The selected participant-level data from *BDC-PIC-SURE* is now connected back to the original data file. The data is connected using DRS URIs, a GA4GH standard used to allow access to data in a single, standard way. This allows investigators to refer back to the original source of the *BDC-PIC-SURE* data. This feature is currently available in the data dictionary table with the PFB formatted *BDC-PIC-SURE* data. Note: This is currently available for some studies, but the DRS URIs of other studies are being added regularly.

**Connect Cohort Data to Genomic Information via Sample Identifiers:** Investigators can automatically include sample identifiers when preparing selected cohort data for analysis in *BDC-PIC-SURE*. The sample identifiers allow researchers to connect the phenotypic information to the associated genomic data or other sample types. [Learn more about including sample identifiers here.](https://pic-sure.gitbook.io/nhlbi-biodata-catalyst-powered-by-pic-sure/explore/features-of-explore/prepare-for-analysis)

**Explore Data with Social Determinants of Health (SDOH) Gravity Domains:** Several variables from BDC data have been mapped to SDOH domains from the Gravity Project, a collaborative public-private initiative with the goal of developing consensus-driven data standards to support the collection, use, and exchange of data to address SDOH. These mappings can be used to explore the data in *BDC-PIC-SURE*.&#x20;

### **New user support materials and documentation**

**Video guides to BDC Data Studio Environments:** Three new onboarding videos were created to introduce and orient users to the three kinds of Data Studio environments available on BDC: JupyterLab, RStudio, and SAS Studio. These videos are available on the [Velsera YouTube channel](https://www.youtube.com/playlist?list=PLHYRY81C1euhlIMdf0OPYiWhWAnZSdAnZ) as platform-generated videos.

### **Data Releases**

The table below highlights which studies were included in the 2025-01-15 data release.

The latest release features NHLBI TOPMed projects, including the San Antonio Family Heart Study (SAFHS), Women's Health Initiative (WHI), and the Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing Project, with updates from the Cardiovascular Health Study (CHS). New additions include the study of African Americans, Asthma, Genes, and Environment (SAGE), the Pulmonary Fibrosis Whole Genome Sequencing project, and the Genetic Epidemiology of COPD (COPDGene). Furthermore, the release highlights studies on the Molecular Genetics of Heterotaxy and Related Congenital Heart Defects, and the Collaborative Cohort of Cohorts for COVID-19 Research (C4R) with data from SPIROMICS and Jackson Heart Study (JHS). Featured are several BioLINCC studies, such as the Systolic Blood Pressure Intervention Trial (SPRINT), Heart Failure Network studies, and the Resuscitation Outcomes Consortium (ROC). This release introduces the Multi-Ethnic Study of Atherosclerosis (MESA) Echocardiogram Image Repository and includes data from the Veterans Administration (VA) Million Veteran Program (MVP) as well as the Healthy Lifestyle Program (HeLP).

The data is now available for access across the entire ecosystem.

<table><thead><tr><th width="262">Study Name</th><th width="111">phs I.D. #</th><th width="225">Acronym</th><th width="89">New to BioData Catalyst</th><th width="81">New study version</th></tr></thead><tbody><tr><td>NHLBI TOPMed: San Antonio Family Heart Study (SAFHS)</td><td>phs001215.v4.p2.c1</td><td>topmed-SAFHS_DS-DHD-IRB-PUB-MDS-RD</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Women's Health Initiative (WHI)</td><td>phs001237.v3.p1.c1</td><td>topmed-WHI_HMB-IRB</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Women's Health Initiative (WHI)</td><td>phs001237.v3.p1.c2</td><td>topmed-WHI_HMB-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing Project: Cardiovascular Health Study</td><td>phs001368.v4.p2.c1</td><td>topmed-CHS_HMB-MDS</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing Project: Cardiovascular Health Study</td><td>phs001368.v4.p2.c2</td><td>topmed-CHS_HMB-NPU-MDS</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing Project: Cardiovascular Health Study</td><td>phs001368.v4.p2.c3</td><td>topmed-CHS_DS-CVD-MDS</td><td>Yes</td><td>No</td></tr><tr><td>NHLBI TOPMed: Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing Project: Cardiovascular Health Study</td><td>phs001368.v4.p2.c4</td><td>topmed-CHS_DS-CVD-NPU-MDS</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Whole Genome Sequencing of Venous Thromboembolism (WGS of VTE)</td><td>phs001402.v3.p1.c1</td><td>topmed-Mayo_VTE_GRU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: My Life Our Future (MLOF) Research Repository of Patients with Hemophilia A (Factor VIII Deficiency) or Hemophilia B (Factor IX Deficiency)</td><td>phs001515.v2.p2.c1</td><td>topmed-MLOF_HMB-PUB</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v3.p2.c1</td><td>topmed-IPF_DS-ILD-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v3.p2.c2</td><td>topmed-IPF_DS-LD-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v3.p2.c3</td><td>topmed-IPF_DS-PFIB-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v3.p2.c4</td><td>topmed-IPF_DS-PUL-ILD-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v3.p2.c5</td><td>topmed-IPF_HMB-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>TRanscriptomic ANalySis of left ventriCulaR gene Expression (TRANSCRibE)</td><td>phs001679.v1.p1.c1</td><td>heartfailure-TRANSCRibE_GRU</td><td>Yes</td><td>No</td></tr><tr><td>TRanscriptomic ANalySis of left ventriCulaR gene Expression (TRANSCRibE)</td><td>phs001679.v1.p1.c2</td><td>heartfailure-TRANSCRibE_DS-CI</td><td>Yes</td><td>No</td></tr><tr><td>NHLBI TOPMed: Pediatric Cardiac Genomics Consortium (PCGC)'s Congenital Heart Disease Biobank</td><td>phs001735.v2.p1.c1</td><td>topmed-PCGC_CHD_HMB</td><td>No</td><td>No</td></tr><tr><td>NHLBI TOPMed: Pediatric Cardiac Genomics Consortium (PCGC)'s Congenital Heart Disease Biobank</td><td>phs001735.v2.p1.c2</td><td>topmed-PCGC_CHD_DS-CHD</td><td>No</td><td>No</td></tr><tr><td>Molecular Genetics of Heterotaxy and Related Congenital Heart Defects</td><td>phs001814.v1.p1.c1</td><td>heartfailure-MolGen_CHD_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)</td><td>phs002909.v1.p1.c1</td><td>COVID19-C4R_SPIROMICS_GRU</td><td> No</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)</td><td>phs002909.v1.p1.c2</td><td>COVID19-C4R_SPIROMICS_GRU-NPU</td><td>No</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)</td><td>phs002909.v1.p1.c3</td><td>COVID19-C4R_SPIROMICS_DS-COPD</td><td>No</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)</td><td>phs002909.v1.p1.c4</td><td>COVID19-C4R_SPIROMICS_DS-COPD-NPU</td><td>No</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)</td><td>phs002909.v1.p1.c5</td><td>COVID19-C4R_SPIROMICS_GRU-COL</td><td>No</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)</td><td>phs002909.v1.p1.c6</td><td>COVID19-C4R_SPIROMICS_GRU-COL-NPU</td><td>No</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)</td><td>phs002909.v1.p1.c7</td><td>COVID19-C4R_SPIROMICS_DS-COPD-COL</td><td>No</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)</td><td>phs002909.v1.p1.c8</td><td>COVID19-C4R_SPIROMICS_DS-COPD-COL-NPU</td><td>No</td><td>No</td></tr><tr><td>Adult Observational Cohort Study (RC_Adult)</td><td>phs003463.v3.p2.c1</td><td>RECOVER-RC_Adult_GRU</td><td>No</td><td>Yes</td></tr><tr><td>Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)</td><td>phs003483.v1.p1.c1</td><td>BioLINCC-BL_SPRINT_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Surgical Treatment for Ischemic Heart Failure (STICH-BioLINCC)</td><td>phs003493.v1.p1.c1</td><td>BioLINCC-BL_STICH_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Heart Failure Network Aldosterone Targeted Neurohormonal Combined with Natriuresis Therapy - (HFN ATHENA-BioLINCC)</td><td>phs003506.v1.p1.c1</td><td>BioLINCC-BL_HFN_ATHENA_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Heart Failure Network - Effectiveness of Ultrafiltration in Treating People with Acute Decompensated Heart Failure and Cardiorenal Syndrome (HFN CARRESS - BioLINCC)</td><td>phs003510.v1.p1.c1</td><td>BioLINCC-BL_HFN_CARRESS_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Sickle Cell Disease Natural History Data Resource (SCD NHDR)</td><td>phs003529.v1.p1.c1</td><td>CureSC-SCD_NHDR_GRU-IRB</td><td>No</td><td>No</td></tr><tr><td>Heart Failure Network - Nitrate's Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction (HFN NEAT-BioLINCC)</td><td>phs003548.v1.p1.c1</td><td>BioLINCC-BL_HFN-NEAT_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Heart Failure Network - Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (HFN RELAX-BioLINCC)</td><td>phs003565.v1.p1.c1</td><td>BioLINCC-BL_HFN-RELAX_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Heart Failure Network - Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea (HFN ROSE-BioLINCC)</td><td>phs003589.v1.p1.c1</td><td>BioLINCC-BL_HFN-ROSE_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION-BioLINCC)</td><td>phs003599.v1.p1.c1</td><td>BioLINCC-BL_HF-ACTION_HMB</td><td>Yes</td><td>No</td></tr><tr><td>Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION-BioLINCC)</td><td>phs003599.v1.p1.c2</td><td>BioLINCC-BL_HF-ACTION_HMB-NPU</td><td>Yes</td><td>No</td></tr><tr><td>Heart Failure Network: Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF (HFN INDIE-BioLINCC)</td><td>phs003667.v1.p1.c1</td><td>BioLINCC-BL_HFN-INDIE_GRU</td><td>Yes</td><td>No</td></tr><tr><td>CONNECTS Master Protocol for Clinical Trials targeting Macro- and Micro-Immuno-Thrombosis, Vascular Hyperinflammation, and Hypercoagulability and Renin-Angiotensin-Aldosterone System (RAAS) in Hospitalized Patients with COVID-19 (ACTIV-4 Host Tissue)</td><td>phs003708.v1.p1.c1</td><td>COVID19-ACTIV4_HostTissue_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Acute Respiratory Distress Network (ARDSNet) Study 04 Assessment of Low Tidal Volume and Elevated End-Expiratory Volume to Obviate Lung Injury (ALVEOLI-BioLINCC)</td><td>phs003714.v1.p1.c1</td><td>BioLINCC-BL_ARDSNet_ALVEOLI_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry (Cardiac Epistry) Version 3 (ROC-Cardiac Epistry 3-BioLINCC)</td><td>phs003726.v1.p1.c1</td><td>BioLINCC-BL_ROC_Cardiac_Epistry_3_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Beta-Blocker Evaluation in Survival Trial (BEST-BioLINCC)</td><td>phs003730.v1.p1.c1</td><td>BioLINCC-BL_BEST_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Acute Respiratory Distress Network (ARDSNet) Studies 06 and 08 Prospective, Randomized, Multicenter Trial of Aerosolized Albuterol Versus Placebo for the Treatment of Acute Lung Injury (ALTA) (ARDSNet-ALTA-BioLINCC)</td><td>phs003743.v1.p1.c1</td><td>BioLINCC-BL_ARDSNet_ALTA_HMB-MDS</td><td>Yes</td><td>No</td></tr><tr><td>NHLBI TOPMed: Coronary Artery Risk Development in Young Adults (CARDIA)</td><td>phs001612.v3.p3.c1</td><td>topmed-CARDIA_HMB-IRB</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Coronary Artery Risk Development in Young Adults (CARDIA)</td><td>phs001612.v3.p3.c2</td><td>topmed-CARDIA_HMB-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Genetic Epidemiology of COPD (COPDGene)</td><td>phs000951.v6.p5.c2</td><td>topmed-COPDGene_DS-CS-RD</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Genetic Epidemiology of COPD (COPDGene)</td><td>phs000951.v6.p5.c1</td><td>topmed-COPDGene_HMB</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: The Genetic Epidemiology of Asthma in Costa Rica</td><td>phs000988.v6.p1.c1</td><td>topmed-CRA_DS-ASTHMA-IRB-MDS-RD</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v4.p3.c1</td><td>topmed-IPF_DS-ILD-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v4.p3.c2</td><td>topmed-IPF_DS-LD-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v4.p3.c3</td><td>topmed-IPF_DS-PFIB-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v4.p3.c4</td><td>topmed-IPF_DS-PUL-ILD-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Pulmonary Fibrosis Whole Genome Sequencing</td><td>phs001607.v4.p3.c5</td><td>topmed-IPF_HMB-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Study of African Americans, Asthma, Genes and Environment (SAGE)</td><td>phs000921.v5.p2.c2</td><td>topmed-SAGE_DS-LD-IRB-COL</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Women's Health Initiative (WHI)</td><td>phs001237.v4.p2.c1</td><td>topmed-WHI_HMB-IRB</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Women's Health Initiative (WHI)</td><td>phs001237.v4.p2.c2</td><td>topmed-WHI_HMB-IRB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Multi-Ethnic Study of Atherosclerosis (MESA)</td><td>phs003017.v1.p1.c1</td><td>COVID19-C4R_MESA_HMB</td><td>No</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Multi-Ethnic Study of Atherosclerosis (MESA)</td><td>phs003017.v1.p1.c2</td><td>COVID19-C4R_MESA_HMB-NPU</td><td>No</td><td>No</td></tr><tr><td>Acute Respiratory Distress Network (ARDSNet) Studies 01 and 03 Lower Versus Higher Tidal Volume, Ketoconazole Treatment and Lisofylline Treatment (ARMA/KARMA/LARMA) (ARDSNet-ARMA/KARMA/LARMA-BioLINCC)</td><td>phs003734.v1.p1.c1</td><td>BioLINCC-BL_ARDSNet_ARMA_KARMA_LARMA_GRU</td><td>Yes</td><td>No</td></tr><tr><td>ARDSNet 07-08: Randomized, Blinded, Placebo-Controlled, Multi-Center Trial of Omega-3 Fatty Acid, Gamma-Linolenic Acid, and Antioxidants in Acute Lung Injury or ARDS (OMEGA) (ARDSNet-Omega-BioLINCC)</td><td>phs003744.v1.p1.c1</td><td>BioLINCC-BL_ARDSNet_Omega_HMB-MDS</td><td>Yes</td><td>No</td></tr><tr><td>Acute Respiratory Distress Network (ARDSNet) Studies 10 and 12 Statins for Acutely Injured Lungs from Sepsis (SAILS) (ARDSNet-SAILS-BioLINCC)</td><td>phs003736.v1.p1.c1</td><td>BioLINCC-BL_ARDSNet_SAILS_HMB-MDS</td><td>Yes</td><td>No</td></tr><tr><td>Prevention and Early Treatment of Acute Lung Injury (PETAL) - Low Tidal Volume Universal Support Feasibility of Recruitment for Interventional Trial (LOTUS FRUIT) (PETAL-LOTUS FRUIT-BioLINCC)</td><td>phs003791.v1.p1.c1</td><td>BioLINCC-BL_PETAL_LOTUS_FRUIT_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Resuscitation Outcomes Consortium (ROC) Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Ventricular Tachycardia (ALPS)</td><td>phs003784.v1.p1.c1</td><td>BioLINCC-BL_ROC_ALPS_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Resuscitation Outcomes Consortium (ROC) Cardiac Epidemiologic Registry (Cardiac Epistry) Versions 1 and 2 (ROC-Cardiac Epistry 1 and 2-BioLINCC)</td><td>phs003803.v1.p1.c1</td><td>BioLINCC-BL_ROC_Cardiac_Epistry_1_2_GRU</td><td>Yes</td><td>No</td></tr><tr><td>Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT-BioLINCC)</td><td>phs003665.v1.p1.c1</td><td>BioLINCC-BL_TOPCAT_HMB-MDS</td><td>Yes</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Jackson Heart Study (JHS)</td><td>phs002907.v1.p1.c4</td><td>COVID19-C4R_JHS_DS-FDO-IRB</td><td>Yes</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Jackson Heart Study (JHS)</td><td>phs002907.v1.p1.c2</td><td>COVID19-C4R_JHS_DS-FDO-NPU-IRB</td><td>Yes</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Jackson Heart Study (JHS)</td><td>phs002907.v1.p1.c3</td><td>COVID19-C4R_JHS_HMB-IRB</td><td>Yes</td><td>No</td></tr><tr><td>Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Jackson Heart Study (JHS)</td><td>phs002907.v1.p1.c1</td><td>COVID19-C4R_JHS_HMB-NPU-IRB</td><td>Yes</td><td>No</td></tr><tr><td>Veterans Administration (VA) Million Veteran Program (MVP) Summary Results from Omics Studies</td><td>phs001672.v11.p1.c1</td><td>dbGaP-MVP_HMB-MDS</td><td>Yes</td><td>No</td></tr><tr><td>Multi-Ethnic Study of Atherosclerosis (Echocardiogram Image Repository)</td><td>phs003702.v1.p1.c1</td><td>imaging-img_MESA_ECHO_HMB</td><td>Yes</td><td>No</td></tr><tr><td>Multi-Ethnic Study of Atherosclerosis (Echocardiogram Image Repository)</td><td>phs003702.v1.p1.c2</td><td>imaging-img_MESA_ECHO_HMB-NPU</td><td>Yes</td><td>No</td></tr><tr><td>Incentives and Case Management to Improve Cardiac Care: Healthy Lifestyle Program (HeLP)</td><td>phs003737.v1.p1.c1</td><td>Individual_Study-UTMB_HeLP_GRU</td><td>Yes</td><td>No</td></tr></tbody></table>

### **Planned upcoming Data Releases**

<table><thead><tr><th width="260">Study Name</th><th width="114">phs I.D. #</th><th width="195">Acronym</th><th width="87">New to BioData Catalyst</th><th>New study version</th></tr></thead><tbody><tr><td>Resuscitation Outcomes Consortium (ROC) Trauma Epidemiologic Registry (Trauma Epistry) (ROC-Trauma Epistry-BioLINCC)</td><td>phs003809.v1.p1.c1</td><td>BioLINCC-BL_ROC-Trauma_Epistry_GRU</td><td>Yes</td><td>No</td></tr><tr><td>BioLINCC The Women's Health Initiative (WHI)</td><td>phs003824.v1.c1</td><td>imaging-img_WHI_HMB</td><td>Yes</td><td>No</td></tr><tr><td>BioLINCC The Women's Health Initiative (WHI)</td><td>phs003824.v1.c2</td><td>imaging-img_WHI_HMB-NPU</td><td>Yes</td><td>No</td></tr><tr><td>The Jackson Heart Study (JHS)</td><td>phs003747.v1.p1.c1</td><td>imaging-img_JHS_HMB-IRB-NPU</td><td>Yes</td><td>No</td></tr><tr><td>The Jackson Heart Study (JHS)</td><td>phs003747.v1.p1.c2</td><td>imaging-img_JHS_DS-FDO-IRB-NPU</td><td>Yes</td><td>No</td></tr><tr><td>The Jackson Heart Study (JHS)</td><td>phs003747.v1.p1.c3</td><td>imaging-img_JHS_HMB-IRB</td><td>Yes</td><td>No</td></tr><tr><td>The Jackson Heart Study (JHS)</td><td>phs003747.v1.p1.c4</td><td>imaging-img_JHS_DS-FDO-IRB</td><td>Yes</td><td>No</td></tr><tr><td>Resuscitation Outcomes Consortium (ROC) Hypertonic Saline (HS) Trial Shock Study and Traumatic Brain Injury Study (TBI) (ROC-HS/TBI-BioLINCC)</td><td>phs003777.v1.p1.c1</td><td>BioLINCC-BL_ROC_HS_TBI-GRU</td><td>Yes</td><td>No</td></tr><tr><td>NHLBI TOPMed: Genomic Activities such as Whole Genome Sequencing and Related Phenotypes in the Framingham Heart Study</td><td>phs000974.v6.p5.c1</td><td>topmed-FHS_HMB-IRB-MDS</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: Genomic Activities such as Whole Genome Sequencing and Related Phenotypes in the Framingham Heart Study</td><td>phs000974.v6.p5.c2</td><td>topmed-FHS_HMB-IRB-NPU-MDS</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: MESA and MESA Family AA-CAC</td><td>phs001416.v4.p1.c1</td><td>topmed-MESA_HMB</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed: MESA and MESA Family AA-CAC</td><td>phs001416.v4.p1.c2</td><td>topmed-MESA_HMB-NPU</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed - NHGRI CCDG: Genes-Environments and Admixture in Latino Asthmatics (GALA II)</td><td>phs000920.v6.p4.c2</td><td>topmed-GALAII_DS-LD-IRB-COL</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed - NHGRI CCDG: Atherosclerosis Risk in Communities (ARIC)</td><td>phs001211.v5.p4.c1</td><td>topmed-ARIC_HMB-IRB-NPU-MDS</td><td>No</td><td>Yes</td></tr><tr><td>NHLBI TOPMed - NHGRI CCDG: Atherosclerosis Risk in Communities (ARIC)</td><td>phs001211.v5.p4.c2</td><td>topmed-ARIC_DS-CVD-IRB-NPU-MDS</td><td>No</td><td>Yes</td></tr></tbody></table>

### **For detailed platform release notes please consult the following resources:**

*BDC Powered by Gen3* release notes\
[*BDC Powered by Terra* release notes](https://support.terra.bio/hc/en-us/categories/360000693572)\
[*BDC Powered by Seven Bridges* release notes](https://sb-biodatacatalyst.readme.io/blog)\
[*BDC Powered by PIC-SURE* release notes](https://pic-sure.gitbook.io/nhlbi-biodata-catalyst-r-powered-by-pic-sure/release-notes/release-notes)